【2h】

Microbiome and Schizophrenia

机译:微生物组和精神分裂症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Schizophrenia is a debilitating psychiatric disorder that contributes to a large cascade of emotional, occupational, and cognitive impairments. Treatment involves combination of psychosocial rehabilitation and pharmacotherapy. In most cases, chronic antipsychotic therapy is required to treat symptoms, avoid relapse and attenuate episode recurrence – . Despite the growing number of pharmacologic agents for the treatment of schizophrenia, many patients do not adequately benefit from or tolerate currently available antipsychotics – . Existing typical and atypical antipsychotic medications are relatively equally effective in treating what are known as the positive symptoms of schizophrenia. What has been prominently lacking, however, is an agent that also treats the negative symptoms as well as substantial cognitive impairment 1–3. Despite growing numbers of antipsychotic drugs for the treatment of schizophrenia, the management of this disorder remains to be a major challenge. Therefore, there is a need to find new strategies to improve treatment plans for schizophrenia patients. New studies have found that people with schizophrenia have differences in their gut biomes compared to people without the mental disorder , . The researchers found a smaller subset of bacteria that were clearly different between schizophrenia patients and those without the disorder. They report that when they introduced samples of the subset from the schizophrenia patients into the biomes of healthy mice, the mice displayed behavior changes , . The researchers claim that their results show that people with schizophrenia have differences in their gut biomes and that those differences may be associated with schizophrenia symptoms. They suggest that certain bacteria in the biome may be associated with schizophrenia-related symptoms due to interactions with microbiota gut-brain amino acids, and possibly lipid metabolic pathways. In conclusion, researchers have started to find interesting links between the naturally occurring bacteria that live in our guts, and things we’ve traditionally attributed to the brain. Things like our mood, feelings, and even thoughts .
机译:精神分裂症是一种使人衰弱的精神疾病,可导致大量的情绪,职业和认知障碍。治疗涉及社会心理康复和药物治疗的结合。在大多数情况下,需要使用慢性抗精神病药物治疗症状,避免复发并减轻发作的复发–。尽管用于治疗精神分裂症的药物越来越多,但许多患者仍不能充分受益或无法耐受目前可用的抗精神病药–。现有的典型和非典型抗精神病药物在治疗精神分裂症的阳性症状方面相对同等有效。然而,目前最缺乏的是一种能同时治疗负面症状和严重认知障碍的药物1-3。尽管用于治疗精神分裂症的抗精神病药物的数量不断增加,但该疾病的管理仍是主要挑战。因此,需要寻找新的策略来改善精神分裂症患者的治疗计划。新研究发现精神分裂症患者的肠道生物群区与精神病患者的肠道群区有所差异,。研究人员发现,精神分裂症患者和无精神分裂症患者之间的细菌明显较小。他们报告说,当他们将精神分裂症患者的亚组样本引入健康小鼠的生物群系时,小鼠表现出行为变化。研究人员声称,他们的结果表明,精神分裂症患者的肠道生物群系存在差异,这些差异可能与精神分裂症的症状有关。他们认为,生物群系中的某些细菌可能由于与微生物群肠脑氨基酸的相互作用以及可能的脂质代谢途径而与精神分裂症相关的症状有关。总之,研究人员已经开始发现生活在我们肠道中的天然细菌与传统上归因于大脑的事物之间的有趣联系。诸如我们的心情,感觉甚至思想之类的事情。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号